Opposing effects by pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide on hippocampal synaptic transmission
- 31 December 2003
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 184 (2) , 778-784
- https://doi.org/10.1016/s0014-4886(03)00300-5
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Short-Term Synaptic PlasticityAnnual Review of Physiology, 2002
- Differential Effects of PACAP-38 on Synaptic Responses in Rat Hippocampal CA1 RegionLearning & Memory, 2001
- PACAP Protects Hippocampal Neurons against Apoptosis: Involvement of JNK/SAPK Signaling PathwayaAnnals of the New York Academy of Sciences, 1998
- Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptideBrain Research, 1996
- Tissue-specific and Developmental Expression of Pituitary Adenylate Cyclase-activating Polypeptide (PACAP) Receptors in Rat BrainEuropean Journal of Neuroscience, 1996
- Neuropeptides, Adenylyl Cyclase, and Memory StorageScience, 1995
- Potentiation of cAMP responses by metabotropic glutamate receptors depresses excitatory synaptic transmission by a kinase-independent mechanismNeuron, 1994
- The probability of transmitter release at a mammalian central synapseNature, 1993
- Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cellsBiochemical and Biophysical Research Communications, 1989
- Polypeptide with Broad Biological Activity: Isolation from Small IntestineScience, 1970